Nagi Bioscience (CH)
Healthcare
HQ: Lausanne, Switzerland
Investors: 1
EPFL spin-off developing 'Organism-on-a-Chip' technology for automated drug and chemical testing. Founded by Italian CEO Matteo Cornaglia.
Investors (1)
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Excellis Holding | Current | - | - | Website |
Get these signals delivered weekly
Deals, exits, fundraises, and key hires from funds active in Italy — straight to your inbox.
Get Signals